Fitness to Practise Cases
This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.
Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:
- Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
- Employers & HR Teams – to learn about professional accountability and compliance.
- Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.
Why it matters:
The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.
Use the form below to search for and filter cases that match your interests
Page 11 of 54
Pharmacist Struck Off for Dishonest Destruction of 20 Million Diazepam Tablets and Unlawful Wholesale Stockpiling
Allegations This case concerned a pharmacist who operated two London pharmacies and held a Wholesale Dealer Authorisation for conventional medicines but not for controlled drugs. Between 2013 and 2016, the registrant purchased extraordinarily large quantities of Class C controlled drugs, primarily diazepam and zopiclone. The evidence demonstrated that approximately 20 million diazepam tablets were purchased […]
2 March 2026
Pharmacist Suspended Again for Dishonest Indemnity Insurance Declarations and Prolonged Uninsured Practice
This case concerns a principal review hearing before the General Pharmaceutical Council’s Fitness to Practise Committee on 26 February 2026, following a previous six-month Suspension Order imposed in August 2025. The registrant, a superintendent pharmacist operating two private pharmacy premises, had previously been found to have practised for a prolonged period without professional indemnity insurance […]
1 March 2026
Boots Pharmacist Branch Manager Suspended for Dishonest High-Value Refunds Without Receipts
Allegations This case concerned a pharmacist who was employed as both Responsible Pharmacist and Store Manager at a Boots pharmacy-only store in Welwyn Garden City. The matter arose after Boots’ Fraud Analytics Team identified a series of high-value refunds processed between February and March 2023, totalling £3,769.93 . The refunded items were primarily electrical and […]
NI Superintendent has Conditions Extended for Further 2 Years for Private Prescriptions Deception
This case concerns a superintendent pharmacist who established and oversaw an online private prescription dispensing service that gave rise to serious regulatory concerns about governance, transparency, record keeping, and patient safety. The matter has a lengthy procedural history, with multiple reviews since the original finding of impairment in early 2023, culminating in a further two-year […]
28 February 2026
Pharmacy Technician Issued Warning for Unauthorised Access to Patient Medical Records
Allegations On 26 February 2026, the General Pharmaceutical Council’s Investigating Committee considered an allegation concerning the registrant and determined that a warning was the appropriate outcome . The case arose from events in February 2024, when the registrant accessed the medical records of two individuals, referred to as Patient A and Patient B. The Committee […]
27 February 2026
Pharmacist Suspended for Controlled Drug Governance Failures and Inadequate Oversight as Superintendent
Allegations This case concerned a pharmacist who was the Superintendent Pharmacist (SI), owner, and regular Responsible Pharmacist (RP) of a community pharmacy. The concerns arose following an NHS England inspection in July 2022 and subsequent GPhC inspections. At the time of the first inspection, the registrant was off sick following a heart attack. However, inspectors […]
NI Pharmacist Given Criminal Convictions for Unlawful Supply and MDS Failures
Allegations This case concerned a pharmacist who, over a prolonged period of approximately ten months (January to October 2010), engaged in repeated unlawful supply of prescription-only medicines (POMs) and multiple dispensing errors while acting as the Responsible Pharmacist in a community pharmacy setting . The registrant pleaded guilty to and was convicted of 13 summary […]
26 February 2026
Weight Loss Pharmacist Prescriber Suspended for Accessing Patient Phone Numbers to Initiate Sexual WhatsApp Relationships
Allegations This case concerned a pharmacist independent prescriber working remotely for IQ Doctor, an online service providing weight management treatment, including the GLP-1 receptor agonist Mounjaro (tirzepatide). As part of remote prescribing protocols, patients were required to submit photographs to support BMI verification and monitor weight-loss progress. On 29 November 2024, Patient A submitted an […]
24 February 2026
Pharmacist Suspended for Governance Breakdown in High-Volume Private Prescribing Case involving Patient Death
Allegations This case concerned a pharmacist independent prescriber and Superintendent Pharmacist who owned and operated an online pharmacy providing private prescribing services. Over a two-year period (January 2020 – December 2021), the registrant prescribed 18,683 private prescriptions through an online questionnaire-based model. The medicines included: These medicines are not benign. Several require appropriate clinical assessment, […]
NI Pharmacist Issued 3-Year Warning After Illicit Use and Supply of Sustanon (Testosterone)
Allegations This case concerned a pharmacist who admitted to the prolonged, unlawful acquisition and self-administration of testosterone, as well as the unlawful supply of Sustanon, a branded testosterone preparation. Testosterone is classified as a Prescription Only Medicine (POM) and is listed as a Schedule 4 Part II controlled drug under the Misuse of Drugs Regulations […]
23 February 2026